1. Novell JR, Hilson AJW. Iodine 131-lipiodol for hepatocellular carcinoma: the benefits of targeting [editorial]. J Nucl Med 1994; 35:1318–1320.
2. Nakakuma K, Tashiro S, Uemura K, et al. Studies on anticancer treatments with an oily anticancer drug injected into the ligated hepatic artery for hepatic cancer. Nichidoku Iho 1979; 24:675–682.
3. Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985; 154:25–29.
4. Raoul JL, Guyader D, Bretagne JF, et al. Prospective randomized trial of chemo embolisation versus intra-arterial injection of 131-I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepathology 1997; 26:1156–1161.
5. Lau WY, Leung TWT, Ho SKW, et al. Adjuvant intra-arterial lipiodol iodine 131 for resectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999; 353:797–801.